Filing Details
- Accession Number:
- 0000899243-21-031826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-05 19:41:39
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-05 19:41:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1111485 | Rxsight Inc. | RXST | Ophthalmic Goods (3851) | 943268801 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1431159 | Juliet Bakker Tammenoms | C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-03 | 12,500 | $16.00 | 18,359 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 1,863,613 | $0.00 | 1,863,613 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-08-03 | 125,000 | $16.00 | 1,988,613 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-08-03 | 500,000 | $16.00 | 500,000 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series G Preferred Stock | Disposition | 2021-08-03 | 1,613,423 | $0.00 | 1,613,423 | $0.00 |
| Common Stock | Series H Preferred Stock | Disposition | 2021-08-03 | 242,013 | $0.00 | 242,013 | $0.00 |
| Series H Preferred Stock | Warrant (right to buy) | Disposition | 2021-08-03 | 36,302 | $0.00 | 36,302 | $12.40 |
| Common Stock | Series H Preferred Stock | Acquisiton | 2021-08-03 | 36,302 | $0.00 | 36,302 | $0.00 |
| Common Stock | Series H Preferred Stock | Disposition | 2021-08-03 | 28,125 | $0.00 | 28,125 | $0.00 |
| Common Stock | Series H Preferred Stock | Disposition | 2021-08-03 | 8,177 | $0.00 | 8,177 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | 2017-02-24 | No | 4 | M | Indirect | |
| 36,302 | No | 4 | M | Indirect | ||
| 8,177 | No | 4 | F | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- Shares and warrant are held by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
- Shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LPP and may be deemed to share voting and investment power over the securities held by LPF. LPF, LPP and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
- The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
Billionaire Hedge Funds
